Jpmorgan Chase & Co »

Xtant Med Hldgs shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Xtant Med Hldgs (XTNT) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Xtant Med Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Xtant Med Hldgs held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xtant Med Hldgs by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $97 87 1.13
2023-09-30 $35 32 1.09
2018-12-31 $0 89 0.00

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Xtant Med Hldgs

OrbiMed Advisors
Nantahala Capital Management
Vanguard Group
AMH Equity
AWM Investment Company
Crescent Grove Advisors
Millennium Management
Citigroup
Citadel Advisors
Midwest Professional Planners
Goldman Sachs Group
Bank of America Corporation
Private Advisor
Wells Fargo & Company
Advisor Group Holdings

View all funds holding Xtant Med Hldgs